Cargando…
Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
Intralesional Mycobacterium bovis bacillus Calmette–Guérin (BCG) has long been a relatively inexpensive therapy for inoperable cutaneous metastatic melanoma (CMM), although intralesional BCG skin mechanisms remain understudied. We analyzed intralesional BCG-treated CMM lesions combined with in vitro...
Autores principales: | Lardone, Ricardo D., Chan, Alfred A., Lee, Agnes F., Foshag, Leland J., Faries, Mark B., Sieling, Peter A., Lee, Delphine J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554507/ https://www.ncbi.nlm.nih.gov/pubmed/28848560 http://dx.doi.org/10.3389/fimmu.2017.00965 |
Ejemplares similares
-
Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
por: Yang, Junbao, et al.
Publicado: (2017) -
Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011) -
Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
por: Palmer, Mitchell V., et al.
Publicado: (2018) -
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Li, Junli, et al.
Publicado: (2021) -
γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases
por: Ramos, Romela, et al.
Publicado: (2015)